-
Adaptive enrichment designs: applications and challenges
Noah Simon
Clinical Trail Methodology: Clinical Investigation
-
Adaptive enrichment designs: applications and challenges
Noah Simon
Clinical Trail Methodology: Clinical Investigation
-
Adaptive enrichment designs: applications and challenges
Noah Simon
Clinical Trail Methodology: Clinical Investigation
-
Adaptive enrichment designs: applications and challenges
Noah Simon
Clinical Trail Methodology: Clinical Investigation
-
Adaptive enrichment designs: applications and challenges
Noah Simon
Clinical Trail Methodology: Clinical Investigation
-
Adaptive enrichment designs: applications and challenges
Noah Simon
Clinical Trail Methodology: Clinical Investigation
-
Adaptive enrichment designs: applications and challenges
Noah Simon
Clinical Trail Methodology: Clinical Investigation
-
Adaptive enrichment designs: applications and challenges
Noah Simon
Clinical Trail Methodology: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation